Results 301 to 310 of about 2,033,720 (344)

Matrix Metalloproteinase-9 and Postoperative Outcomes in Carotid Endarterectomy: A Systematic Review. [PDF]

open access: yesJ Clin Med
Gonçalves-Silva J   +4 more
europepmc   +1 more source

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death across cardio‐kidney‐metabolic diseases: A meta‐analysis of randomized clinical trials

open access: yesEuropean Journal of Heart Failure, EarlyView.
Abstract Aims Sudden cardiac death (SCD) is a prevalent cause of mortality among patients with cardio‐kidney‐metabolic (CKM) diseases. Mineralocorticoid receptor antagonists (MRAs) reduce the risk of SCD in patients with left ventricular dysfunction, but it is unclear if similar effects are expected across different CKM risk populations irrespective of
Pedro Marques   +2 more
wiley   +1 more source

Counseling and Prescription of Physical Exercise in Medical Consultations in Portugal: The Clinician's Perspective. [PDF]

open access: yesHealthcare (Basel)
Quintas Oliveira R   +6 more
europepmc   +1 more source

Wages of Civil Servants [PDF]

open access: yes
Mário Centeno, Pedro Portugal
core  

Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR‐HF2‐DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials

open access: yesEuropean Journal of Heart Failure, EarlyView.
Differences in baseline characteristics between major trials of intravenous (IV) iron therapy in heart failure. LVEF, left ventricular ejection fraction; SGLT2, sodium–glucose cotransporter 2. Aims Prior randomized trials have reported conflicting evidence regarding the efficacy of intravenous (IV) iron in patients with heart failure with reduced ...
Stefan D. Anker   +44 more
wiley   +1 more source

Understanding Acceleration-Based Load Metrics: From Concepts to Implementation. [PDF]

open access: yesSensors (Basel)
Freitas J   +4 more
europepmc   +1 more source

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy